Alphabet as of June 30, 2024
Portfolio Holdings for Alphabet
Alphabet holds 42 positions in its portfolio as reported in the June 2024 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Gitlab Class A Com (GTLB) | 24.6 | $485M | 9.8M | 49.72 | |
Arm Holdings Sponsored Ads (ARM) | 16.3 | $321M | 2.0M | 163.62 | |
Revolution Medicines (RVMD) | 10.4 | $206M | 5.3M | 38.81 | |
Crowdstrike Hldgs Cl A (CRWD) | 8.3 | $164M | 428k | 383.19 | |
Freshworks Class A Com (FRSH) | 7.9 | $157M | 12M | 12.69 | |
Dex (DXCM) | 6.0 | $118M | 1.0M | 113.38 | |
Uipath Cl A (PATH) | 4.5 | $89M | 7.0M | 12.68 | |
Prime Medicine (PRME) | 3.9 | $77M | 15M | 5.14 | |
Snowflake Cl A (SNOW) | 3.7 | $72M | 536k | 135.09 | |
Verve Therapeutics (VERV) | 3.1 | $60M | 12M | 4.88 | |
Planet Labs Pbc Com Cl A (PL) | 3.0 | $59M | 32M | 1.86 | |
Tempus Ai Cl A (TEM) | 2.7 | $54M | 1.6M | 35.00 | |
Sana Biotechnology (SANA) | 0.8 | $15M | 2.8M | 5.46 | |
Relay Therapeutics (RLAY) | 0.5 | $10M | 1.6M | 6.52 | |
Vera Therapeutics Cl A (VERA) | 0.4 | $8.7M | 241k | 36.18 | |
Lyell Immunopharma (LYEL) | 0.4 | $8.5M | 5.9M | 1.45 | |
Oscar Health Cl A (OSCR) | 0.4 | $7.6M | 482k | 15.82 | |
Beam Therapeutics (BEAM) | 0.4 | $7.5M | 322k | 23.43 | |
Tscan Therapeutics (TCRX) | 0.3 | $6.3M | 1.1M | 5.85 | |
Illumina (ILMN) | 0.3 | $5.6M | 54k | 104.38 | |
Monte Rosa Therapeutics (GLUE) | 0.3 | $5.5M | 1.5M | 3.74 | |
Dianthus Therapeutics (DNTH) | 0.3 | $5.4M | 209k | 25.88 | |
Desktop Metal Com Cl A (DM) | 0.2 | $4.6M | 1.1M | 4.13 | |
Foghorn Therapeutics (FHTX) | 0.1 | $2.9M | 501k | 5.75 | |
Tenaya Therapeutics (TNYA) | 0.1 | $2.8M | 916k | 3.10 | |
Fractyl Health (GUTS) | 0.1 | $2.8M | 663k | 4.27 | |
Autolus Therapeutics Spon Adr (AUTL) | 0.1 | $2.4M | 698k | 3.48 | |
Benson Hill Common Stock | 0.1 | $2.3M | 15M | 0.15 | |
Barinthus Biotherapeutics Pl Ads (BRNS) | 0.1 | $2.1M | 1.5M | 1.40 | |
Kronos Bio (KRON) | 0.1 | $1.8M | 1.4M | 1.24 | |
Rani Therapeutics Hldgs Com Cl A (RANI) | 0.1 | $1.7M | 449k | 3.80 | |
Rapt Therapeutics (RAPT) | 0.1 | $1.6M | 540k | 3.05 | |
Taysha Gene Therapies Com Shs (TSHA) | 0.1 | $1.4M | 641k | 2.24 | |
Spero Therapeutics (SPRO) | 0.1 | $1.2M | 890k | 1.30 | |
EXACT Sciences Corporation (EXAS) | 0.0 | $980k | 23k | 42.25 | |
Alector (ALEC) | 0.0 | $798k | 176k | 4.54 | |
Hyperfine Com Cl A (HYPR) | 0.0 | $764k | 899k | 0.85 | |
Cortexyme (QNCX) | 0.0 | $142k | 189k | 0.75 | |
Fulcrum Therapeutics (FULC) | 0.0 | $88k | 14k | 6.20 | |
Repligen Corporation (RGEN) | 0.0 | $48k | 383.00 | 126.06 | |
Invitae (NVTAQ) | 0.0 | $0 | 236k | 0.00 | |
Cue Health (HLTHQ) | 0.0 | $0 | 27k | 0.00 |